Health News

CAMBRIDGE, England--(BUSINESS WIRE)--CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, has introduced two new animal microphysiological system (MPS) models that enhance translatability in preclinical drug safety and toxicology assessments to its Contract Research Services (CRS). Building upon the Company’s FDA-recognized drug induced liver injury (DILI) assay, the expanded offering enables rapid, comparative studi...

BOSTON--(BUSINESS WIRE)--Emulate, Inc., the world leader in Organ-on-a-Chip technology, today announced the commercial launch of the AVA™ Emulation System, a self-contained instrument that cultures, incubates, and images up to 96 independent Organ-Chip samples in a single run. AVA delivers an unprecedented magnitude of in vivo-level insights faster than animal models while cutting consumable costs four-fold and in-lab labor by half compared to current generation technologies. These transformati...

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, announced today that Addenbrookes Hospital of Cambridge University Hospital Foundation and Trust will be the first site in the United Kingdom and European continent to offer histotripsy to both NHS and private patients. This was made possible through a generous donation by the Li Ka Shing Foundation (LKSF) as well as the expedited limited market access granted b...

LOUGHTON, England--(BUSINESS WIRE)--O.C. Tanner: Workplace Injuries Are Reduced with Employee Appreciation...

CULVER CITY, Calif.--(BUSINESS WIRE)--Papaya Veterinary Care®, a forward-thinking network of primary care and emergency veterinary hospitals, proudly announces the opening of its newest location in Culver City at 11924 Washington Boulevard. The new clinic will be led by Dr. Tony Nitido, Medical Director and experienced Southern California veterinarian. At nearly 4,000 square feet, the newly constructed facility is designed to create a calm, welcoming environment for pets and the people who love...

DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) officially accepted the company’s application for marketing authorization of pimicotinib as a Class 1 innovative drug for adult patients with tenosynovial giant cell tumors (TGCT) requiring systemic treatment. The submission follows the granting of Priority Review to pimicotinib by the CDE in...

DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) officially accepted the company’s application for marketing authorization of pimicotinib as a Class 1 innovative drug for adult patients with tenosynovial giant cell tumors (TGCT) requiring systemic treatment. The submission follows the granting of Priority Review to p...

RESTON, Va.--(BUSINESS WIRE)--Regula, a global developer of forensic devices and identity verification (IDV) solutions, has made its inaugural appearance in the KuppingerCole Leadership Compass for Identity Verification 2025. Mentioned in the Innovation Leaders category, the company is recognized for its 100% in-house R&D, forensic-grade technology, global document coverage, and advanced liveness detection capabilities. Specializing in IDV and cybersecurity industry analysis, KuppingerCole...

BOSTON & SYDNEY--(BUSINESS WIRE)--BERKSHIRE HATHAWAY SPECIALTY INSURANCE LAUNCHES LIFE SCIENCE, BIOTECH & PHARMACEUTICAL (LBP) MANAGEMENT LIABILITY POLICY IN AUSTRALIA...

QUÉBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions to inflammatory diseases, today announced the appointment of Dr. André Boulet as Chief Executive Officer of the Corporation, replacing Mr. Luc Gregoire who will continue in the new role of Executive Vice-President Strategy of the Corporation, effective June 9, 2025. “As we enter a new phase of development, we ar...